Scienture Holdings, Inc. (SCNX)
NASDAQ: SCNX · Real-Time Price · USD
0.3730
+0.0032 (0.87%)
At close: Sep 4, 2026, 4:00 PM EDT
0.3651
-0.0079 (-2.12%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Scienture Holdings Employees
As of December 31, 2025, Scienture Holdings had 9 total employees, including 4 full-time and 5 part-time employees. The number of employees decreased by 10 or -52.63% compared to the previous year.
Employees
9
Change (1Y)
-10
Growth (1Y)
-52.63%
Revenue / Employee
$91,257
Profits / Employee
-$4,216,925
Market Cap
15.32M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 9 | -10 | -52.63% | 4 | 5 |
| Dec 31, 2024 | 19 | 0 | - | 14 | 5 |
| Jun 30, 2024 | 19 | - | - | 14 | 5 |
| Dec 31, 2023 | 19 | - | - | 14 | 5 |
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| Merck & Co. | 75,000 |
| AbbVie | 57,000 |
| Eli Lilly and Company | 50,000 |
| Advanced Biomed | 31 |
| Passage Bio | 24 |
| Lisata Therapeutics | 21 |
| NeuroOne Medical Technologies | 18 |
SCNX News
- 11 days ago - DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM) - Accesswire
- 21 days ago - DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update - Accesswire
- 21 days ago - Scienture announces commercial launch of Rezenopy Nasal Spray - TheFly
- 23 days ago - DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026 - Accesswire
- 24 days ago - SCIENTURE Reports Q2 2026 Results with Approximately 510% Sequential Revenue Growth from Q1 2026 and Significant Improvement in Operating Performance - GlobeNewsWire
- 26 days ago - SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray - GlobeNewsWire
- 26 days ago - DataMeds AI Provides Update on Corexa Health's Pharmacy Division - Accesswire
- 4 weeks ago - DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division - Accesswire